Go Pro
→ Elon Musk to Trigger Next AI Wave on November 11th? (From Brownstone Research) (Ad)tc pixel
NASDAQ:QCLS

Mymd Pharmaceuticals Q4 2025 Earnings Report

Mymd Pharmaceuticals logo
$1.71 0.00 (0.00%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$1.65 -0.06 (-3.51%)
As of 05:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Mymd Pharmaceuticals EPS Results

Actual EPS
$6.11
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Mymd Pharmaceuticals Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Mymd Pharmaceuticals Announcement Details

Quarter
Q4 2025
Date
4/15/2026
Time
After Market Closes
Conference Call Date
Wednesday, April 15, 2026
Conference Call Time
7:00AM ET

Conference Call Resources

Mymd Pharmaceuticals Earnings Headlines

Q/C Technologies Appoints Veteran Silicon Photonics Engineer Yossef Ehrlichman as Founding Manager, Photonic Integrated Circuit (PIC) Development
August 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338427/0/en/q-c-technologies-appoints-veteran-silicon-photonics-engineer-yossef-ehrlichman-as-founding-manager-photonic-integrated-circuit-pic-development.html
Q/C Technologies Relocates Headquarters to San Francisco in Proximity to World-Class Engineering Experts for Photonic Computing and Optical AI Inference Initiative
July 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/01/3320730/0/en/q-c-technologies-relocates-headquarters-to-san-francisco-in-proximity-to-world-class-engineering-experts-for-photonic-computing-and-optical-ai-inference-initiative.html
Print this before your next trade
Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97. It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon.tc pixel
 |  Profits Run (Ad)
Q/C Technologies Relocates Headquarters to San Francisco in Proximity to World-Class Engineering Experts for Photonic Computing and Optical AI Inference Initiative
June 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/30/3319790/0/en/q-c-technologies-relocates-headquarters-to-san-francisco-in-proximity-to-world-class-engineering-experts-for-photonic-computing-and-optical-ai-inference-initiative.html
See More Mymd Pharmaceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Mymd Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mymd Pharmaceuticals and other key companies, straight to your email.

About Mymd Pharmaceuticals

Mymd Pharmaceuticals (NASDAQ:QCLS) is a clinical-stage biopharmaceutical company focused on developing novel therapies for immune-related and other serious diseases. The company has worked on product candidates designed to address conditions involving inflammation, immune system dysfunction, and age-related disease processes.

The company’s pipeline has included drug development programs in areas such as autoimmune and inflammatory disorders, with an emphasis on advancing compounds through preclinical and clinical evaluation. MyMD Pharmaceuticals is based in the United States and has operated as a research-driven biotechnology company centered on bringing new therapeutic options to market.

Because company details can change over time and reliable, up-to-date information on leadership and current geographic operations is limited, this description is intentionally brief and limited to broadly verifiable business information.

View Mymd Pharmaceuticals Profile
Earnings Tools